164 related articles for article (PubMed ID: 35587324)
1. Association of markers of tumor aggressivity and cognition in women with breast cancer before adjuvant treatment: The Thinking and Living with Cancer Study.
Root JC; Zhou X; Ahn J; Small BJ; Zhai W; Bethea T; Carroll JE; Cohen HJ; Dilawari A; Extermann M; Graham D; Isaacs C; Jacobsen PB; Jim H; McDonald BC; Nakamura ZM; Patel SK; Rentscher K; Saykin AJ; Van Dyk K; Mandelblatt JS; Ahles TA
Breast Cancer Res Treat; 2022 Jul; 194(2):413-422. PubMed ID: 35587324
[TBL] [Abstract][Full Text] [Related]
2. Cognitive function prior to systemic therapy and subsequent well-being in older breast cancer survivors: Longitudinal findings from the Thinking and Living with Cancer Study.
Kobayashi LC; Cohen HJ; Zhai W; Zhou X; Small BJ; Luta G; Hurria A; Carroll J; Tometich D; McDonald BC; Graham D; Jim HSL; Jacobsen P; Root JC; Saykin AJ; Ahles TA; Mandelblatt J
Psychooncology; 2020 Jun; 29(6):1051-1059. PubMed ID: 32154959
[TBL] [Abstract][Full Text] [Related]
3. Associating persistent self-reported cognitive decline with neurocognitive decline in older breast cancer survivors using machine learning: The Thinking and Living with Cancer study.
Van Dyk K; Ahn J; Zhou X; Zhai W; Ahles TA; Bethea TN; Carroll JE; Cohen HJ; Dilawari AA; Graham D; Jacobsen PB; Jim H; McDonald BC; Nakamura ZM; Patel SK; Rentscher KE; Saykin AJ; Small BJ; Mandelblatt JS; Root JC
J Geriatr Oncol; 2022 Nov; 13(8):1132-1140. PubMed ID: 36030173
[TBL] [Abstract][Full Text] [Related]
4. Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity?
Mandelblatt JS; Stern RA; Luta G; McGuckin M; Clapp JD; Hurria A; Jacobsen PB; Faul LA; Isaacs C; Denduluri N; Gavett B; Traina TA; Johnson P; Silliman RA; Turner RS; Howard D; Van Meter JW; Saykin A; Ahles T
J Clin Oncol; 2014 Jun; 32(18):1909-18. PubMed ID: 24841981
[TBL] [Abstract][Full Text] [Related]
5. Associations between pathologic tumor features and preadjuvant therapy cognitive performance in women diagnosed with breast cancer.
Koleck TA; Bender CM; Sereika SM; Ryan CM; Ghotkar P; Brufsky AM; Jankowitz RC; McAuliffe PF; Clark BZ; Conley YP
Cancer Med; 2017 Feb; 6(2):339-348. PubMed ID: 28083945
[TBL] [Abstract][Full Text] [Related]
6. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
[TBL] [Abstract][Full Text] [Related]
7. An Examination of the Longitudinal Relationship Between Cognitive Function and Physical Activity Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study.
Tometich DB; Mosher CE; Cyders M; McDonald BC; Saykin AJ; Small BJ; Zhai W; Zhou X; Jim HSL; Jacobsen P; Ahles TA; Root JC; Graham D; Patel SK; Mandelblatt J
Ann Behav Med; 2023 Apr; 57(3):237-248. PubMed ID: 36356044
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease-related biomarkers and cancer-related cognitive decline: the thinking and living with cancer study.
Mandelblatt J; Dage JL; Zhou X; Small BJ; Ahles TA; Ahn J; Artese A; Bethea TN; Breen EC; Carroll JE; Cohen HJ; Extermann M; Graham D; Isaacs C; Jim HSL; Mcdonald BC; Nakamura ZM; Patel SK; Rebeck GW; Rentscher KE; Root JC; Russ KA; Tometich DB; Turner RS; Van Dyk K; Zhai W; Huang LW; Saykin AJ
J Natl Cancer Inst; 2024 May; ():. PubMed ID: 38788675
[TBL] [Abstract][Full Text] [Related]
9. Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy.
Dhillon HM; Tannock IF; Pond GR; Renton C; Rourke SB; Vardy JL
J Cancer Surviv; 2018 Apr; 12(2):178-185. PubMed ID: 29080061
[TBL] [Abstract][Full Text] [Related]
10. Prediction of cognitive decline in older breast cancer survivors: the Thinking and Living with Cancer study.
McDeed AP; Van Dyk K; Zhou X; Zhai W; Ahles TA; Bethea TN; Carroll JE; Cohen HJ; Nakamura ZM; Rentscher KE; Saykin AJ; Small BJ; Root JC; Jim H; Patel SK; Mcdonald BC; Mandelblatt JS; Ahn J
JNCI Cancer Spectr; 2024 Feb; 8(2):. PubMed ID: 38556480
[TBL] [Abstract][Full Text] [Related]
11. A randomised controlled trial evaluating two cognitive rehabilitation approaches for cancer survivors with perceived cognitive impairment.
Vardy JL; Pond GR; Bell ML; Renton C; Dixon A; Dhillon HM
J Cancer Surviv; 2023 Dec; 17(6):1583-1595. PubMed ID: 36241767
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal Relationship Between Frailty and Cognition in Patients 50 Years and Older with Breast Cancer.
Magnuson A; Lei L; Gilmore N; Kleckner AS; Lin FV; Ferguson R; Hurria A; Wittink MN; Esparaz BT; Giguere JK; Misleh J; Bautista J; Mohile SG; Janelsins MC
J Am Geriatr Soc; 2019 May; 67(5):928-936. PubMed ID: 31034595
[TBL] [Abstract][Full Text] [Related]
13. Relationship between cognitive functioning and frailty in older breast cancer survivors.
Ahles TA; Schofield E; Li Y; Ryan E; Root JC; Patel SK; McNeal K; Gaynor A; Tan H; Katheria V; Vazquez J; Traina T; Hurria A
J Geriatr Oncol; 2022 Jan; 13(1):27-32. PubMed ID: 34366276
[TBL] [Abstract][Full Text] [Related]
14. Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study.
Mandelblatt JS; Small BJ; Luta G; Hurria A; Jim H; McDonald BC; Graham D; Zhou X; Clapp J; Zhai W; Breen E; Carroll JE; Denduluri N; Dilawari A; Extermann M; Isaacs C; Jacobsen PB; Kobayashi LC; Holohan Nudelman K; Root J; Stern RA; Tometich D; Turner R; VanMeter JW; Saykin AJ; Ahles T
J Clin Oncol; 2018 Oct; 36(32):JCO1800140. PubMed ID: 30281396
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels of interleukin-6 mediate neurocognitive performance in older breast cancer survivors: The Thinking and Living With Cancer study.
Mandelblatt JS; Small BJ; Zhou X; Nakamura ZM; Cohen HJ; Ahles TA; Ahn J; Bethea TN; Extermann M; Graham D; Isaacs C; Jacobsen PB; Jim HSL; McDonald BC; Patel SK; Rentscher KE; Root JC; Saykin AJ; Tometich DB; Van Dyk K; Zhai W; Breen EC; Carroll JE
Cancer; 2023 Aug; 129(15):2409-2421. PubMed ID: 37096888
[TBL] [Abstract][Full Text] [Related]
16. Perceived cognitive function in breast cancer survivors: evaluating relationships with objective cognitive performance and other symptoms using the functional assessment of cancer therapy-cognitive function instrument.
Von Ah D; Tallman EF
J Pain Symptom Manage; 2015 Apr; 49(4):697-706. PubMed ID: 25240787
[TBL] [Abstract][Full Text] [Related]
17. Evaluating cognitive complaints in breast cancer survivors with the FACT-Cog and quantitative electroencephalography.
Van Dyk K; Hunter AM; Ercoli L; Petersen L; Leuchter AF; Ganz PA
Breast Cancer Res Treat; 2017 Nov; 166(1):157-166. PubMed ID: 28707203
[TBL] [Abstract][Full Text] [Related]
18. Sleep disturbance and neurocognitive outcomes in older patients with breast cancer: Interaction with genotype.
Carroll JE; Small BJ; Tometich DB; Zhai W; Zhou X; Luta G; Ahles TA; Saykin AJ; Nudelman KNH; Clapp JD; Jim HS; Jacobsen PB; Hurria A; Graham D; McDonald BC; Denduluri N; Extermann M; Isaacs C; Dilawari AA; Root J; Stern RA; Mandelblatt JS;
Cancer; 2019 Dec; 125(24):4516-4524. PubMed ID: 31553501
[TBL] [Abstract][Full Text] [Related]
19. Cognitive effects of adjuvant endocrine therapy in older women treated for early-stage breast cancer: a 1-year longitudinal study.
Underwood EA; Jerzak KJ; Lebovic G; Rochon PA; Elser C; Pritchard KI; Tierney MC
Support Care Cancer; 2019 Aug; 27(8):3035-3043. PubMed ID: 30610433
[TBL] [Abstract][Full Text] [Related]
20. Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study.
Chen BT; Sethi SK; Jin T; Patel SK; Ye N; Sun CL; Rockne RC; Haacke EM; Root JC; Saykin AJ; Ahles TA; Holodny AI; Prakash N; Mortimer J; Waisman J; Yuan Y; Somlo G; Li D; Yang R; Tan H; Katheria V; Morrison R; Hurria A
Breast Cancer Res; 2018 May; 20(1):38. PubMed ID: 29720224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
